Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex

BACKGROUND: For the past few years, gene-therapy has recently shown considerable clinical benefit in cancer therapy, and the applications of gene therapies in cancer treatments continue to increase perennially. EZH2, an ideal candidate for tumor gene therapy, plays an important role in the tumorigen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiang, Hua, Yuanqi, Xu, Guangya, Deng, Senyi, Yang, Daoke, Gao, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472285/
https://www.ncbi.nlm.nih.gov/pubmed/31043779
http://dx.doi.org/10.2147/IJN.S189871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472285/
https://www.ncbi.nlm.nih.gov/pubmed/31043779
http://dx.doi.org/10.2147/IJN.S189871

Ejemplares similares